Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Press Releases

Parenteral Drug Association Announces Measures to Support Pharma/Biopharma Industries during Covid-19 Pandemic

For Immediate Release:
03/27/2020
Media Inquiries:
Walt Morris
/ [email protected] /
301-656-5900, x. 148

Bethesda, Md. – The Parenteral Drug Association (PDA) announced that it is suspending membership expirations retroactively to March 1 and continuing until the end of June. All members will continue to enjoy the benefits of membership, even if you are unable to pay due to the impact of the corona virus pandemic. 

“The PDA team wants everyone in our community to stay safe during this difficult time,” said PDA President/CEO Richard Johnson. “PDA remains dedicated to providing our members with the useful tools and resources you need, particularly when as they face unexpected challenges.”

While PDA puts in place alternative solutions for training and conferences, here is a partial list of the benefits you can take advantage of immediately as you continue to work and advance your career: